Since Oxysophocarpine sensitized the Lag‐3 immunotherapy effect of CD8+ T against HCC and Fibrinogen‐like‐protein 1 (FGL1) was recently identified as a major ligand for the inhibitory receptor Lag‐3 that mediated CD8+T cells suppression.18 The gene discussed is CD8A; the disease is hepatocellular carcinoma.